Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 11, no: 0 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4IDX9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 161 | 165 | PF00656 | 0.496 |
CLV_C14_Caspase3-7 | 227 | 231 | PF00656 | 0.475 |
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.546 |
CLV_NRD_NRD_1 | 268 | 270 | PF00675 | 0.485 |
CLV_NRD_NRD_1 | 308 | 310 | PF00675 | 0.650 |
CLV_NRD_NRD_1 | 316 | 318 | PF00675 | 0.699 |
CLV_NRD_NRD_1 | 37 | 39 | PF00675 | 0.624 |
CLV_NRD_NRD_1 | 79 | 81 | PF00675 | 0.497 |
CLV_PCSK_FUR_1 | 314 | 318 | PF00082 | 0.627 |
CLV_PCSK_KEX2_1 | 122 | 124 | PF00082 | 0.636 |
CLV_PCSK_KEX2_1 | 268 | 270 | PF00082 | 0.491 |
CLV_PCSK_KEX2_1 | 316 | 318 | PF00082 | 0.679 |
CLV_PCSK_KEX2_1 | 74 | 76 | PF00082 | 0.401 |
CLV_PCSK_KEX2_1 | 81 | 83 | PF00082 | 0.445 |
CLV_PCSK_PC1ET2_1 | 122 | 124 | PF00082 | 0.619 |
CLV_PCSK_PC1ET2_1 | 74 | 76 | PF00082 | 0.449 |
CLV_PCSK_PC1ET2_1 | 81 | 83 | PF00082 | 0.534 |
CLV_PCSK_PC7_1 | 264 | 270 | PF00082 | 0.564 |
CLV_PCSK_SKI1_1 | 174 | 178 | PF00082 | 0.431 |
CLV_PCSK_SKI1_1 | 207 | 211 | PF00082 | 0.449 |
CLV_PCSK_SKI1_1 | 268 | 272 | PF00082 | 0.532 |
DOC_CKS1_1 | 43 | 48 | PF01111 | 0.472 |
DOC_CYCLIN_RxL_1 | 36 | 45 | PF00134 | 0.554 |
DOC_CYCLIN_yCln2_LP_2 | 43 | 49 | PF00134 | 0.548 |
DOC_MAPK_gen_1 | 147 | 157 | PF00069 | 0.468 |
DOC_MAPK_gen_1 | 213 | 219 | PF00069 | 0.463 |
DOC_MAPK_MEF2A_6 | 134 | 141 | PF00069 | 0.538 |
DOC_PP1_RVXF_1 | 189 | 196 | PF00149 | 0.301 |
DOC_PP4_FxxP_1 | 198 | 201 | PF00568 | 0.444 |
DOC_WW_Pin1_4 | 129 | 134 | PF00397 | 0.625 |
DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.594 |
DOC_WW_Pin1_4 | 42 | 47 | PF00397 | 0.490 |
LIG_14-3-3_CanoR_1 | 134 | 140 | PF00244 | 0.499 |
LIG_14-3-3_CanoR_1 | 14 | 24 | PF00244 | 0.557 |
LIG_Actin_WH2_2 | 212 | 228 | PF00022 | 0.537 |
LIG_FHA_1 | 11 | 17 | PF00498 | 0.612 |
LIG_FHA_1 | 152 | 158 | PF00498 | 0.434 |
LIG_FHA_2 | 286 | 292 | PF00498 | 0.566 |
LIG_FHA_2 | 297 | 303 | PF00498 | 0.573 |
LIG_G3BP_FGDF_1 | 193 | 198 | PF02136 | 0.291 |
LIG_GBD_Chelix_1 | 24 | 32 | PF00786 | 0.461 |
LIG_LIR_Apic_2 | 197 | 201 | PF02991 | 0.495 |
LIG_LIR_Gen_1 | 294 | 304 | PF02991 | 0.480 |
LIG_LIR_Gen_1 | 61 | 69 | PF02991 | 0.377 |
LIG_LIR_Nem_3 | 192 | 198 | PF02991 | 0.511 |
LIG_LIR_Nem_3 | 294 | 300 | PF02991 | 0.480 |
LIG_LIR_Nem_3 | 45 | 50 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 61 | 65 | PF02991 | 0.271 |
LIG_LYPXL_yS_3 | 47 | 50 | PF13949 | 0.509 |
LIG_PDZ_Class_3 | 322 | 327 | PF00595 | 0.695 |
LIG_PTAP_UEV_1 | 317 | 322 | PF05743 | 0.650 |
LIG_PTB_Apo_2 | 63 | 70 | PF02174 | 0.386 |
LIG_PTB_Phospho_1 | 63 | 69 | PF10480 | 0.384 |
LIG_SH3_3 | 315 | 321 | PF00018 | 0.640 |
LIG_SH3_3 | 43 | 49 | PF00018 | 0.519 |
LIG_SH3_3 | 9 | 15 | PF00018 | 0.617 |
LIG_SUMO_SIM_anti_2 | 153 | 161 | PF11976 | 0.470 |
LIG_SUMO_SIM_anti_2 | 18 | 25 | PF11976 | 0.486 |
LIG_TYR_ITSM | 43 | 50 | PF00017 | 0.464 |
LIG_WRC_WIRS_1 | 195 | 200 | PF05994 | 0.421 |
LIG_WRC_WIRS_1 | 59 | 64 | PF05994 | 0.387 |
MOD_CDK_SPK_2 | 129 | 134 | PF00069 | 0.544 |
MOD_CK1_1 | 319 | 325 | PF00069 | 0.735 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.647 |
MOD_CK2_1 | 260 | 266 | PF00069 | 0.484 |
MOD_CK2_1 | 290 | 296 | PF00069 | 0.493 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.462 |
MOD_GlcNHglycan | 18 | 21 | PF01048 | 0.455 |
MOD_GlcNHglycan | 257 | 260 | PF01048 | 0.618 |
MOD_GlcNHglycan | 318 | 321 | PF01048 | 0.679 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.526 |
MOD_N-GLC_1 | 183 | 188 | PF02516 | 0.450 |
MOD_N-GLC_2 | 96 | 98 | PF02516 | 0.444 |
MOD_NEK2_1 | 16 | 21 | PF00069 | 0.473 |
MOD_PKA_1 | 316 | 322 | PF00069 | 0.646 |
MOD_PKA_2 | 225 | 231 | PF00069 | 0.483 |
MOD_PKA_2 | 249 | 255 | PF00069 | 0.552 |
MOD_PKA_2 | 316 | 322 | PF00069 | 0.690 |
MOD_PKB_1 | 314 | 322 | PF00069 | 0.637 |
MOD_Plk_1 | 295 | 301 | PF00069 | 0.525 |
MOD_Plk_2-3 | 236 | 242 | PF00069 | 0.556 |
MOD_Plk_2-3 | 296 | 302 | PF00069 | 0.590 |
MOD_Plk_4 | 207 | 213 | PF00069 | 0.314 |
MOD_Plk_4 | 243 | 249 | PF00069 | 0.546 |
MOD_Plk_4 | 58 | 64 | PF00069 | 0.363 |
MOD_ProDKin_1 | 129 | 135 | PF00069 | 0.610 |
MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.593 |
MOD_ProDKin_1 | 42 | 48 | PF00069 | 0.484 |
MOD_SUMO_for_1 | 73 | 76 | PF00179 | 0.434 |
MOD_SUMO_rev_2 | 172 | 181 | PF00179 | 0.307 |
TRG_ENDOCYTIC_2 | 47 | 50 | PF00928 | 0.515 |
TRG_ER_diArg_1 | 267 | 269 | PF00400 | 0.515 |
TRG_ER_diArg_1 | 314 | 317 | PF00400 | 0.684 |
TRG_ER_diArg_1 | 80 | 83 | PF00400 | 0.481 |
TRG_NES_CRM1_1 | 89 | 103 | PF08389 | 0.499 |
TRG_Pf-PMV_PEXEL_1 | 183 | 187 | PF00026 | 0.471 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P915 | Leptomonas seymouri | 51% | 100% |
A0A0S4IVP5 | Bodo saltans | 27% | 100% |
A0A1X0P0S9 | Trypanosomatidae | 31% | 100% |
A0A3R7NVI0 | Trypanosoma rangeli | 30% | 100% |
A0A3S7XC03 | Leishmania donovani | 100% | 100% |
A4HQ81 | Leishmania braziliensis | 65% | 99% |
D0A431 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
E9ATZ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4Q0J6 | Leishmania major | 92% | 100% |
V5DK35 | Trypanosoma cruzi | 34% | 99% |